Biodexa Pharmaceuticals (BDRX) Change in Cash (2015 - 2022)
Biodexa Pharmaceuticals (BDRX) posted Change in Cash of -$4.3 million for Q4 2022, up 5.16% sequentially from -$4.5 million in Q3 2022, and up 5.22% YoY from -$4.1 million in Q4 2021.
Biodexa Pharmaceuticals (BDRX) Change in Cash (2015 - 2022) Analysis & Trends
Biodexa Pharmaceuticals has reported Change in Cash for 5 years, with the latest figure at -$4.3 million in Q4 2022.
- Quarterly Change in Cash rose 5.22% year-over-year to -$4.3 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$17.9 million (up 32.88% YoY) and the FY2025 annual result came in at $9.1 million, up 263.93% from the prior year.
- Change in Cash grew to -$4.3 million in Q4 2022 per BDRX's latest filing, from -$4.5 million in the prior quarter.
- Over five years, Change in Cash peaked at $8.6 million in Q4 2019 and troughed at -$9.0 million in Q4 2020.
- A 4-year average of -$3.8 million and a median of -$4.5 million in 2021 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2020 and 2021: Change in Cash plunged 204.11% in 2020, then surged 49.85% in 2021.
- Over 4 years, Change in Cash stood at $8.6 million in 2019, then plunged by 204.11% to -$9.0 million in 2020, then jumped by 49.85% to -$4.5 million in 2021, then gained by 5.22% to -$4.3 million in 2022.
- According to Business Quant data, Change in Cash over the past three periods registered -$4.3 million, -$4.5 million, and -$4.5 million for Q4 2022, Q3 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Biodexa Pharmaceuticals | 64,325.41 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -4.26 Mn |
| Sep 14, 2022 | -4.49 Mn |
| Dec 31, 2021 | -4.50 Mn |
| Sep 17, 2021 | -4.64 Mn |
| Dec 31, 2020 | -8.97 Mn |
| Sep 10, 2020 | -8.55 Mn |
| Dec 31, 2019 | 8.61 Mn |
| Dec 31, 2015 | -21.51 Mn |